C4 Therapeutics (CCCC) Net Equity Issued and Repurchased (2019 - 2026)
C4 Therapeutics' Net Equity Issued and Repurchased came in at $32.94 million for Q2 2026.
Powered by 
Analysis
C4 Therapeutics (CCCC) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, C4 Therapeutics reported Net Equity Issued and Repurchased of $33.66 million; for FY2025, it came in at $107,000, down 86.2% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -77.7% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $778,000 in FY2024, $58,000 in FY2023 (-92.5%), $777,000 in FY2022 (-66.7%) and $2.33 million in FY2021 (-98.8%).
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q4 2020.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2024 (growth of 826.8%), and the weakest in Q2 2023 (a decline of 99.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | C4 Therapeutics | 393.93 Mn | -549.34 Mn | - | 186,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 186,000.00 |
| Jun 30, 2026 | 33.73 Mn |
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | -7.54 Mn |
| Sep 30, 2025 | 7.61 Mn |
| Mar 31, 2025 | -155,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 410,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 260,000.00 |
| Dec 31, 2021 | 752,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | -148,000.00 |
API Access
C4 Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();